Analyst firms · Maxim Group · ZVRA
Maxim Group ZVRA price target and rating history
Zevra Therapeutics Inc. (ZVRA) · Health Care
Maxim Group rates Zevra Therapeutics Inc. (ZVRA) Buy with a $25 price target, as of its latest action on Sep 24, 2024. It has published 3 rating actions on ZVRA since March 2023, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $25
- Median target, all firms
- Too few
- Actions on ZVRA
- 3
Maxim Group price target on ZVRA
Every Maxim Group rating on ZVRA
- Sep 24, 2024
- Apr 2, 2024
- Mar 17, 2023
Questions about Maxim Group and ZVRA
- What is Maxim Group's price target for ZVRA?
- Maxim Group's latest stated price target for Zevra Therapeutics Inc. (ZVRA) is $25, from its action on Sep 24, 2024.
- What is Maxim Group's rating on ZVRA?
- Maxim Group rates ZVRA Buy, a bullish rating, as of Sep 24, 2024.
- When did Maxim Group last change its view on ZVRA?
- On Sep 24, 2024, Maxim Group raises its price target to $25 from $18, keeps Buy.
All Maxim Group ratingsZVRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.